Kakimoto Y, Akazawa S (1970) Isolation and identification of N-G,N-G- and N-G,N’-G-dimethyl- arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem 245: 5751–5758PubMedGoogle Scholar

Achan V, Broadhead M, Malaki M et al. (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23: 1455–1459PubMedCrossRefGoogle Scholar

Kielstein JT, Boger RH, Bode-Boger SM et al. (2002) Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13: 170–176PubMedGoogle Scholar

Leiper JM, Santa MJ, Chubb A et al. (1999) Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 343: 209–214PubMedCrossRefGoogle Scholar

Vallance P, Leone A, Calver A et al. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572–575PubMedCrossRefGoogle Scholar

Martens-Lobenhoffer J, Bode-Boger SM (2006) Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 52: 488–493PubMedCrossRefGoogle Scholar

Causse E, Siri N, Arnal JF et al. (2000) Determination of asymmetrical dimethylarginine by capillary electrophoresis-laser-induced fluorescence. J Chromatogr B Biomed Sci Appl 741: 77–83PubMedCrossRefGoogle Scholar

Schulze F, Wesemann R, Schwedhelm E et al. (2004) Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med 42: 1377–1383PubMedCrossRefGoogle Scholar

Schulze F, Maas R, Freese R et al. (2005) Determination of a reference value for N,N-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest 35: 622–626PubMedCrossRefGoogle Scholar

Zoccali C, Bode-Boger S, Mallamaci F et al. (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358: 2113–2117PubMedCrossRefGoogle Scholar

Fliser D, Kronenberg F, Kielstein JT et al. (2005) Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 16: 2456–2461PubMedCrossRefGoogle Scholar

Ravani P, Tripepi G, Malberti F et al. (2005) Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 16: 2449–2455PubMedCrossRefGoogle Scholar

Meinitzer A, Seelhorst U, Wellnitz B et al. (2007) Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (The Ludwigshafen Risk and Cardiovascular Health Study). Clin Chem 43: 517–526Google Scholar

Mittermayer F, Pleiner J, Krzyzanowska K et al. (2005) Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus. Wien Klin Wochenschr 117: 816–820PubMedCrossRefGoogle Scholar

Richter B, Niessner A, Penka M et al. (2005) Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events. Thromb Haemost 94: 1306–1311PubMedGoogle Scholar

Niebauer J, Clark AL, Webb-Peploe KM et al. (2005) Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure. Eur J Heart Fail 7: 183–188PubMedCrossRefGoogle Scholar

Krzyzanowska K, Mittermayer F, Kopp HP et al. (2004) Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 89: 6277–6281PubMedCrossRefGoogle Scholar

McLaughlin T, Stuhlinger M, Lamendola C et al. (2006) Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab 91: 1896–1900PubMedCrossRefGoogle Scholar

Aslam S, Santha T, Leone A, Wilcox C (2006) Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int 70: 2109–2115PubMedGoogle Scholar

Zoccali C, Kielstein JT (2006) Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease? Curr Opin Nephrol Hypertens 15: 314–320PubMedCrossRefGoogle Scholar

Kielstein JT, Zoccali C (2005) Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 46: 186–202PubMedCrossRefGoogle Scholar